Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2020-07-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AcuSleep in Mild Traumatic Brain Injury (TBI)
NCT01162317
Acupuncture in Traumatic Brain Injury
NCT04369911
Effects of Nurse-Guided BBTi for Improving Insomnia : in Patients at the Recovery Following Traumatic Brain Injury
NCT05402761
The Effects of Acupuncture on Insomnia Among Midlife Women
NCT05684822
Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome
NCT01534130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4-point acupressure group
The 5-point acupressure group will be instructed on the following acupressure points: sanyinjiao (SP6), Zu San Li (ST36), shenmen (TF4), Yongquan (KI-1), and He Gu (LI4).
Bilateral 1.5 min for each point, three times daily for 4 weeks.
Acupressure
Two types acupressure interventions, 5-point and 2-point acupressure groups, will be conducted in the current study.
4 -point acupressure group
The 2-point acupressure group will be instructed on the following acupressure points: He Gu (LI4) and Tai Chong (LV3).
Bilateral 1.5 min for each point, three times daily for 4 weeks.
Acupressure
Two types acupressure interventions, 5-point and 2-point acupressure groups, will be conducted in the current study.
Usual care
The usual care group will be required to maintain their daily activities. Weekly telephone follow-up will be conducted by principle investigator.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupressure
Two types acupressure interventions, 5-point and 2-point acupressure groups, will be conducted in the current study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 20-65 years
* Are able to communicate in Chinese and Mandarin
* Are able to complete the questionnaires
* Complain of tiredness and cannot be restored even after a rest.
* No physical disability and visual impairment
Exclusion Criteria
* had diagnosis of neuropathy and paraesthesia prior to study.
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hsiao-Yean Chiu
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hsiao-Yean Chiu, PhD
Role: PRINCIPAL_INVESTIGATOR
School of Nursing, Taipei Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hsiao-Yean Chiu
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109059-E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.